The Japanese Journal of Dermatology
Online ISSN : 1346-8146
Print ISSN : 0021-499X
ISSN-L : 0021-499X
Search
Advanced search
OR
Browse
Search
Volume 126, Issue 9
Displaying 1-8 of 8 articles from this issue
Show all abstracts
    • |<
    • <
    • 1
    • >
    • >|
Guidelines
Seminar for Medical Education
Original Articles
  • New Treatment of Advanced Melanoma from the Viewpoint of Patient and Hospital Management
    Osamu Yamasaki, Tatsuya Kaji, Hiroshi Umemura, Yoji Hirai, Shin Moriza ...
    2016 Volume 126 Issue 9 Pages 1709-1716
    Published: August 20, 2016
    Released on J-STAGE: August 24, 2016
    DOIhttps://doi.org/10.14924/dermatol.126.1709
    JOURNAL RESTRICTED ACCESS
    Show abstractHide abstract

    Background: The costs of new treatments for patients with advanced melanoma are high, and national medical expenses may increase.

    Methods: We conducted a questionnaire survey about medical expenses for patients with stage II-IV melanoma and compared it by treatment. We compared the medical results in our department in the first half of 2015 with those of the previous year. We also investigated the clinical response, convalescence, and costs of the new treatment in an advanced melanoma patient treated during the period of from September, 2014 to March, 2016.

    Results: In the new treatment group medical expenses became higher than 20% of the cost of living, and a feeling of burden was strong. Medical treatment fees, medical treatment unit price, and medical expenses rates increased in comparison with the previous year. The treatments and duration of treatments in 24 patients undergoing the new treatment varied, but the drug costs were always very high.

    Conclusions: Dermatologists should understand the medical burdens on patient with advanced melanoma, and the hospital management, as well as the problem of national medical expenses; they should be also aware of the economic issues of new treatments for advanced melanoma.

    View full abstract
    Download PDF (530K)
  • Usefulness of Skin Testing for Rosacea-like Dermatitis: Clinical Analysis of 71 Cases
    Tokiko Deguchi, Akiko Ito, Yukiko Masui, Hiroki Fujikawa, Riichiro Abe
    2016 Volume 126 Issue 9 Pages 1717-1724
    Published: August 20, 2016
    Released on J-STAGE: August 24, 2016
    DOIhttps://doi.org/10.14924/dermatol.126.1717
    JOURNAL RESTRICTED ACCESS
    Show abstractHide abstract

    We retrospectively analyzed 71 cases of rosacea-like dermatitis who had undergone skin testing at our hospital between January 2001 and October 2012. The group included one male and 70 females, and had a median age of 52 years. Approximately 40% of the patients were suspected of having contact dermatitis, but had not undergone skin tests. As a result of the skin tests, we diagnosed 70% of the patients (52 cases) as having allergic contact dermatitis; 32 of those cases were caused by cosmetics. Skin testing is a useful tool for investigating the cause of rosacea-like dermatitis and for deciding on appropriate treatment, because many patients with rosacea-like dermatitis actually have contact dermatitis.

    View full abstract
    Download PDF (967K)
Abstracts
Erratum
    • |<
    • <
    • 1
    • >
    • >|
feedback
 Top